RecruitingNCT01656447

Scleroderma Registry & Repository at the Hospital for Special Surgery

The Scleroderma Registry & Repository

Sponsor

Hospital for Special Surgery, New York

Enrollment

300 participants

Start Date

Aug 1, 2006

Study Type

OBSERVATIONAL

Conditions

Scleroderma

Summary

The overall objective of the Scleroderma Registry is to support and promote the basic science and clinical research of this complex rheumatic disease at the Hospital for Special Surgery (HSS). The registry facilitates our understanding of the clinical features, pathobiology, genetics of Scleroderma. This will ultimately lead to a potential treatment for this currently untreatable condition.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with scleroderma. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.